Sacubitril/Valsartan Ameliorates Crizotinib-Induced Cardiotoxicity in Mice
Background: Lung cancer is one of the major cause of death globally. Crizotinib is a first-line drug used in treating non-small-cell lung cancer (NSCLC). However, the pathophysiological mechanisms underlying its cardiotoxicity are unknown. This study investigated the mechanisms of crizotinib-induced...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
IMR Press
2023-07-01
|
| Edice: | Reviews in Cardiovascular Medicine |
| Témata: | |
| On-line přístup: | https://www.imrpress.com/journal/RCM/24/7/10.31083/j.rcm2407192 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|